J&J supports Optometry Giving Sight

Article

Johnson & Johnson Vision Care will support Optometry Giving Sight at the silver level, according to a statement from Dr. Mary Anne Murphy, chair of Optometry Giving Sight

Golden, CO - Johnson & Johnson Vision Care will support Optometry Giving Sight at the silver level, according to a statement from Dr. Mary Anne Murphy, Chair of Optometry Giving Sight.

“We are delighted that Johnson & Johnson Vision Care has joined our campaign to help ensure that people in underserved communities can gain access to affordable, long-term vision care services delivered by locally trained eye-care professionals,” she said.

Optometry Giving Sight was created in 2003 and is the only global fundraising initiative that specifically targets the prevention of blindness and impaired vision due to uncorrected refractive error.

Dr. Murphy noted that while there are still an estimated 600 million people with refractive error blindness or impaired vision, the optometric profession and industry are being increasingly recognized for the leadership role they are playing in helping to eliminate this backlog.

“Through this charity, we continue to see many lives change for the better,” said Dr. Richard Wallingford, Director of Professional Affairs, Vistakon Division of Johnson & Johnson Vision Care, Inc. “Each year Optometry Giving Sight continues to advance its mission to improve the quality of life of people who are needlessly blind or vision impaired simply because they do not have access to an eye exam or a pair of glasses.”

For more articles in this issue of InDispensable, click here.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.